Schizophrenia Clinical Trial
Official title:
Reducing Internalized Stigma In People With Serious Mental Illness
The purpose of this study is to determine if Ending Self-Stigma (ESS), a 9-session group intervention designed to assist veterans with serious mental illness to develop skills (SMI) to effectively cope with stigma and minimize the internalization of stigmatizing beliefs and stereotypes, is more effective in reducing internalized stigma and its associated effects than an active comparison group.
Background:
Stigmatizing beliefs and attitudes about mental illness are prevalent and exposure to stigma
is common among people with mental illness. The negative effects of stigma are compounded
when a veteran with Serious Mental Illness (SMI) internalizes these stigmatizing assumptions
and stereotypes. Internalized stigma refers to the process in which a person with mental
illness cognitively or emotionally absorbs negative messages or stereotypes about mental
illness and comes to believe them and apply them to him/herself. Internalized stigma is
evident among veterans with SMI and can lead to decreased self-efficacy, increased
depression, social withdrawal, and curtailed pursuit of recovery goals.
Objectives:
The investigators developed Ending Self Stigma (ESS), a 9-session group intervention to
assist veterans with SMI to develop skills to effectively cope with stigma and minimize the
internalization of stigmatizing beliefs and stereotypes. The primary objectives of this
project are to compare the effects of ESS to a general health and wellness group in: 1)
reducing internalized stigma and 2) improving proximal psychosocial outcomes (e.g.,
self-efficacy, belonging, recovery orientation). Secondary objectives include assessing the
effects of ESS on improving distal psychosocial outcomes (e.g., quality of life, social
functioning) and examining if improvements are maintained 6-months post-treatment.
Methods:
This study is a randomized trial of veterans with SMI receiving outpatient mental health
services from three VA Medical Centers. Participants are randomly assigned to ESS or a
general health and wellness group, which they attend once a week for 9 weeks. ESS focuses on
teaching strategies/tools to help participants address self-stigma. The health and wellness
group focuses on providing information/ education to help participants better manage
health-related concerns (e.g. physical activity, nutrition). Participants complete
assessments at baseline, post-treatment, and 6-months post-treatment. A two-level mixed
effects model with adjustment for baseline response will be used to address the primary and
secondary aims. Qualitative data on veterans' experiences of and strategies for coping with
internalized stigma are being collected from a subset of veterans from both conditions to
compare experiences of veterans in both groups and explore any reasons for ESS drop-out.
Status:
Data collection for the project is completed. Analysis of 6-month post-treatment assessments
and qualitative interviews are currently being conducted.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |